EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Percutaneous left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter cohort study

Alberto Preda, Claudio Montalto, Luigi De Luca, Angelo Cascio Rizzo, Chiara Ceresa, Ghil Schwarz, Gabriele Paci, Michele Galasso, Marisa Varrenti, Jacopo Andrea Oreglia, Cristina Giannattasio, Achille Gaspardone und 4 weitere

Canadian Journal of Cardiology · 2026

DOI: 10.1016/j.cjca.2026.01.031 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Canadian Journal of Cardiology, 2026. Verfasst von Alberto Preda und 15 weiteren Autor:innen. Beteiligte Einrichtung: De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy. Electronic address: alberto.preda@ospedaleniguarda.it. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Anticoagulants, Embolic Stroke. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left atrial appendage closure (LAAC) may be used in atrial fibrillation patients with previous cardioembolic stroke (CS) despite adequate oral anticoagulation (OAC). The aim of this study was to evaluate the safety and efficacy of the hybrid strategy LAAC and OAC in patients with OAC failure. METHODS: In this multicentre study, patients with an ascertained CS while receiving adequate OAC were divided according to the treatment strategy after the index event (LAAC vs medical therapy [MT] group). Other potential embolic sources were excluded and all patients continued OAC after the index event. The primary end point was a composite of all-cause death, CS, and major bleeding. RESULTS: Among the 109 patients included in the study, 44 (40%) formed the LAAC group and 65 (60%) the MT group. At the median follow-up of 48 (interquartile range, 14) months, the LAAC group reported a lower rate of the primary end point (hazard ratio, 0.398; 95% confidence interval, 0.201-0.781; P = 0.008) and CS recurrence (hazard ratio, 0.273; 95% confidence interval, 0.060-0.852; P = 0.041). Congestive Heart Failure, Hypertension, Age (≥75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female; CHA2DS2-VASc), NIH Stroke Scale (NIHSS), and acute reperfusion therapy predicted the primary end point whereas CHA2DS2-VASc and NIHSS predicted CS recurrence. Results were confirmed in a propensity score-matching analysis. The calculated annualized rate of CS was 2.0 per 100 patient-years in the LAAC group and 7.8 per 100 patient-years in the MT group. CONCLUSIONS: In patients with CS due to OAC failure, the hybrid strategy LAAC and OAC was associated with better long-term outcomes compared with OAC alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Left Atrial Appendage ClosureAtrial FibrillationAnticoagulantsEmbolic StrokeAtrial AppendageHumansFemaleMaleAgedAdministration, OralTreatment OutcomeAged, 80 and overFollow-Up StudiesRetrospective Studies

Stichwörter der Autor:innen

Cardioembolic strokeatrial fibrillationleft atrial appendage closureoral anticoagulation failurestroke recurrence

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy. Electronic address: alberto.preda@ospedaleniguarda.it.
  • De Gasperis Cardio Center, Interventional Cardiology Unit, Niguarda Hospital, Milan, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Electronic address: https://www.linkedin.com/in/cla…
  • De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Electronic address: https://www.linkedin.com/in/luigi-de-lu…
  • Neurology and Stroke Unit, Niguarda Hospital, Milan Italy. Electronic address: https://www.linkedin.com/in/angelo-cascio-rizzo-58a3ba18b/.
  • Neurology and Stroke Unit, Niguarda Hospital, Milan Italy.
  • Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: https://www.linkedin.com/in/gabriele-paci-36b72819b/.

Zitieren

APA

Preda, A., Montalto, C., De Luca, L., Rizzo, A. C., Ceresa, C., Schwarz, G., Paci, G., Galasso, M., Varrenti, M., Oreglia, J. A., Giannattasio, C., Gaspardone, A., Montorfano, M., Sessa, M., Guarracini, F., & Mazzone, P. (2026). Percutaneous left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter cohort study. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2026.01.031

Vancouver

Preda A, Montalto C, De Luca L, Rizzo AC, Ceresa C, Schwarz G, et al. Percutaneous left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter cohort study. Canadian Journal of Cardiology. 2026. doi:10.1016/j.cjca.2026.01.031

BibTeX
@article{Preda2026,
  author = {Preda, Alberto and Montalto, Claudio and De Luca, Luigi and Rizzo, Angelo Cascio and Ceresa, Chiara and Schwarz, Ghil and Paci, Gabriele and Galasso, Michele and Varrenti, Marisa and Oreglia, Jacopo Andrea and Giannattasio, Cristina and Gaspardone, Achille and Montorfano, Matteo and Sessa, Maria and Guarracini, Fabrizio and Mazzone, Patrizio},
  title = {Percutaneous left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter cohort study},
  journal = {Canadian Journal of Cardiology},
  year = {2026},
  doi = {10.1016/j.cjca.2026.01.031}
}
Kostenlos starten →